Research progress on caffeine citrate in the treatment of neonatal respiratory distress syndrome / 中国小儿急救医学
Chinese Pediatric Emergency Medicine
; (12): 721-724, 2022.
Article
em Zh
| WPRIM
| ID: wpr-955135
Biblioteca responsável:
WPRO
ABSTRACT
Neonatal respiratory distress syndrome is typically characterized by progressive exacerbation of respiratory distress shortly after birth, which is more common in preterm infants and has a high disability and mortality rate.Caffeine citrate has been used in the treatment of premature infants with respiratory distress syndrome to enhance the contraction of the diaphragm and optimize the function of respiratory muscles to accelerate the recovery of spontaneous breathing.This review summarized the use of caffeine citrate in premature infants with respiratory distress syndrome.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Pediatric Emergency Medicine
Ano de publicação:
2022
Tipo de documento:
Article